Solve FSHD to invest in Armatus Bio for ARM-201 development
Pharmaceutical Technology
MAY 7, 2025
Venture philanthropy organisation Solve FSHD has announced an investment of $3m in Armatus Bio to support the development of ARM-201.
Wed.May 07, 2025
233 
PharmaTimes Clinical Researcher of the Year – The Americas Awards
Pharma Times
MAY 7, 2025
Demonstrate your skill and prowess by entering this year's awards!
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
UK trumpets a trade deal with India - but pharma isn't happy
pharmaphorum
MAY 7, 2025
Various industries have welcomed news of a trade deal between the UK and India, but Britain's pharma sector isn't among them
Top 100 US Hospitals in 2025: Standouts from Fortune – Premier Rankings
XTalks
MAY 7, 2025
Fortune, in collaboration with Premier, Inc., has unveiled its 2025 list of the 100 Top Hospitals in the United States. This ranking evaluates hospitals based on clinical outcomes, patient experience, operational efficiency and financial health. You can explore this table to view the top 100 hospitals in the US according to Fortune Premier Rankings, with 20 in each category: major teaching hospitals, teaching hospitals, large community hospitals, medium community hospitals and small community h
How to Turn “Check-the-Box” Compliance Trainings Into Real Learning
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance trainings aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, relevant, and maybe even enjoyable! Join expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training programs. You’ll discover creative strategies to turn traditionally dry topics into meaningful learning experiences that resonate and drive real change.
New data could move Enhertu into early breast cancer
pharmaphorum
MAY 7, 2025
AstraZeneca and Daiichi Sankyo's Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage breast cancer for the first time
The Big Picture: Healthcare Data and Interoperability
Rethinking Clinical Trials
MAY 7, 2025
The Big Picture: Healthcare Data and Interoperability Description In this video, Dr. Lesley Curtis explores how data flow into EHRs and move between systems, the role of data standards, and the barriers to building a more streamlined and connected healthcare system. Speaker Lesley Curtis, PhD Professor of Population Health Sciences and Medicine, Duke University Duke Clinical Research Institute Collaboratory Steering Committee Chair Related Electronic Health RecordsBased Phenotyping The post The
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Common Data Models
Rethinking Clinical Trials
MAY 7, 2025
Common Data Models Description In this video, Dr. Lesley Curtis explores Common Data Models (CDMS). Topics include: How CDMs work, customizing CDMs for specific research questions, challenges and benefits of CDMs, and the future of CDMs. Speaker Lesley Curtis, PhD Professor of Population Health Sciences and Medicine, Duke University Duke Clinical Research Institute Collaboratory Steering Committee Chair Related Acquiring Real-World Data Using Electronic Health Record Data in Pragmatic Clinical T
Optimizing Pharma Websites with AI-Driven Search Strategies
Pharma Marketing Network
MAY 7, 2025
Pharmaceutical websites serve a dual purpose: delivering trusted medical content and capturing the attention of health care professionals (HCPs), patients, and researchers. However, traditional search functions often fall short. Visitors can’t find what they need, content goes unseen, and bounce rates increase. This is where AI-driven search can transform the user experience and drive real results for pharma marketers.
The Big Picture: Healthcare Data and Inoperability
Rethinking Clinical Trials
MAY 7, 2025
The Big Picture: Healthcare Data and Inoperability Description In this video, Dr. Lesley Curtis explores how data flow into EHRs and move between systems, the role of data standards, and the barriers to building a more streamlined and connected healthcare system. Speaker Lesley Curtis, PhD Professor of Population Health Sciences and Medicine, Duke University Duke Clinical Research Institute Collaboratory Steering Committee Chair Related Electronic Health RecordsBased Phenotyping The post The Big
Asembia 2025: FDA Uncertainty Sparks Shift Toward Outsourced Pharma Support
Pharmaceutical Commerce
MAY 7, 2025
Will Pih, co-founder, Two Labs, explains how ongoing regulatory uncertainty is slowing clinical trial activity and hiring across the industry, prompting greater reliance on specialty pharmacy services and outsourced support.
Clinical Research White Paper – Enhancing Transparency & Efficiency Throughout the Trial Lifecycle
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
Rare Disease Innovation in an Evolving Industry with Amgen’s Dr. Sumita Bhatta — Episode 207
XTalks
MAY 7, 2025
In this episode, Ayesha speaks with Sumita Bhatta, MD, Vice President and Global Development Therapeutic Head of Rare Disease at Amgen. In the conversation, Dr. Bhatta shares insights on how large pharmaceutical companies like Amgen are approaching innovation and patient-centricity in the rare disease space. She also discusses the unique challenges and opportunities in developing therapies for small patient populations and how cross-functional collaboration drives progress in this complex field.
Pharma Pulse 5/7/25: Teva Pharmaceutical’s Branded Drugs Boost First Quarter Profit, Theriva Biologics Announces Positive VIRAGE Phase IIb Results
Pharmaceutical Commerce
MAY 7, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
May 7, 2025: Results of BackInAction Pragmatic Trial of Acupuncture in Low Back Pain, in This Week’s PCT Grand Rounds
Rethinking Clinical Trials
MAY 7, 2025
Dr. Andrea Cook, Dr. Lynn DeBar, and Dr. Paricia Herman In this Friday’s PCT Grand Rounds, Andrea Cook, Lynn DeBar, and Patricia Herman will present “A Policy-Relevant Pragmatic Trial on Acupuncture Effectiveness for Low Back Pain in Older Adults: Clinical and Cost Outcomes and Lessons Learned.” The Grand Rounds session will be held on Friday, May 9, 2025, at 1:00 pm eastern.
Asembia 2025: GLP-1 Drugs Reshape Reimbursement and Coverage Models
Pharmaceutical Commerce
MAY 7, 2025
Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement challenges, shifting distribution models, and expanding the drugs potential into new therapeutic areas.
Can Your Organization Spot a Conflict Before It’s a Crisis?
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?
Novo cuts forecasts as compounded GLP-1s weigh on sales
Bio Pharma Dive
MAY 7, 2025
The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.
SK Pharmateco Debuts New cGMP Plasmid Suite
Pharmaceutical Commerce
MAY 7, 2025
The move bolsters the CDMOs commitment to cell and gene therapy by incorporating advanced manufacturing and fill-finish capabilities.
Novo Nordisk cuts 2025 outlook due to compounding-hit Wegovy demand
Pharmaceutical Technology
MAY 7, 2025
Novo Nordisk has cut its sales and profits forecasts for 2025 due to lower demand in the US for blockbuster weight loss and diabetes drugs.
SK Pharmteco Debuts New cGMP Plasmid Suite
Pharmaceutical Commerce
MAY 7, 2025
The move bolsters the CDMOs commitment to cell and gene therapy by incorporating advanced manufacturing and fill-finish capabilities.
White Paper - A Roadmap to AI Data Readiness in R&D Labs
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
MHRA grants Promising Innovative Medicine designation to UCB’s DoxTM for TK2d
Pharma Times
MAY 7, 2025
UCBs developmental treatment may be eligible for patient access
Celebrating International Nurse’s Day
Worldwide Clinical Trials
MAY 7, 2025
In celebration of International Nurses Day, we are thrilled to share insights and stories from some of the remarkable nurses on our team. These professionals not only provide exceptional care but also inspire us with their resilience and commitment. We extend our deepest gratitude to all nurses for their unwavering dedication, compassion, and tireless efforts.
FDA grants RMAT status to Opus Genetics’ OPGx-LCA5 gene therapy
Pharmaceutical Technology
MAY 7, 2025
The US FDA has granted regenerative medicine advanced therapy (RMAT) designation to Opus Genetics gene therapy OPGx-LCA5
Powering the Future of Lupus Treatments
Worldwide Clinical Trials
MAY 7, 2025
Lupus presents unique challenges, particularly for patients with lupus nephritis a severe form of the condition that affects kidney function and quality of life. Current treatments often come with side effects and limited effectiveness, leaving patients in need of better options. At Worldwide, were working to accelerate the future of lupus treatments by focusing on innovative, targeted, and more tolerable therapies, utilizing our global reach across 70+ countries, strong partnerships, and commi
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
European biotechs must understand US culture while seeking funding
Pharmaceutical Technology
MAY 7, 2025
At a time when investment has been low in biotech, establishing and maintaining good relationships with investors is vital.
Patent box tax incentives pharmaceutical innovation
Drug Patent Watch
MAY 7, 2025
"The Patent Box Tax Incentive: A Game-Changer for Pharmaceutical Innovation? As the pharmaceutical industry continues to drive groundbreaking research and development, a lesser-known tax incentive has emerged as a key catalyst for innovation. The Patent Box tax regime, introduced in the UK in 2013, has been hailed as a success in fostering a culture of R&D and entrepreneurship.
Expediting parallel drug approval pathways is challenging, but rewarding
Pharmaceutical Technology
MAY 7, 2025
At the Swiss Biotech Day 2025, which took place on 5-6 May in Basel, a panel of experts discussed three drug approval schemes.
Overcoming Study Start-Up Delays: Best Practices for Research Sites
ACRP blog
MAY 7, 2025
This is a sponsored message. In the complex world of clinical research, it’s essential for sites to streamline study start-up processes to better meet their timelines, ensure trial success, and improve financial performance. From coverage analysis to contract execution, each step along the study start-up continuum has unique challenges that require strategic approaches to improve efficiency.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Sarepta shares fall amid FDA’s CBER appointment and weak Elevidys sales
Pharmaceutical Technology
MAY 7, 2025
Sareptas stock dropped by 26% after the FDA named a vocal critic of its gene therapy programme to lead its biologics division.
World Lupus Day 2025: Emerging Pipeline Advances from Biopharma
XTalks
MAY 7, 2025
Every May 10, the global lupus community unites to raise awareness for a disease that often goes unseen, both biologically and socially. The theme of World Lupus Day 2025, Lets Make Lupus Visible Together, highlights the need to shine a light on symptoms, patient experiences and scientific progress. The Hidden Toll of Lupus Nephritis and Beyond Lupus is a chronic autoimmune disease in which the immune system attacks healthy tissue, affecting organs from the kidneys and skin to the brain and hear
EC approves AstraZeneca’s Calquence combo to treat MCL
Pharmaceutical Technology
MAY 7, 2025
The European Commission (EC) has approved AstraZeneca's Bruton's tyrosine kinase (BTK) inhibitor Calquence (acalabrutinib) combo.
Get the 4-1-1 on your 1099s: 5th and 7th Circuits Permit Paying Volume-Based Compensation to Independent Sales Agents
FDA Law Blog
MAY 7, 2025
By Anne K. Walsh & Sophia R. Gaulkin & Steven J. Gonzalez There has been increased enforcement against medical device companies that engage in the pervasive practice of paying third party sales agents based on their volume of sales. This scrutiny was enhanced after the Fourth Circuits ruling in United States v. Mallory , 988 F.3d 730 (4th Cir. 2021), rehg denied , as well as in recent settlements (see, e.g., here ), that all such arrangements violated the federal Anti-Kickback Statute (
Let's personalize your content